|
1.Subject 2.Priciple 3.Materials & Apparatus 4.Procedure 5.Clinical & Significance 6.Result 7.Reference FileSize : 32K / 1.Subject 2.Priciple 3.Materials & Apparatus 4.Procedure 5.Clinical & Significance 6.Result 7.Reference / ¼¼±ÕÀÇ ÀÀÁý¹ÝÀÀÀº º´¿ø±ÕÀÌ ¼÷ÁÖ¿¡ °¨¿°µÇ¸é ¼÷ÁÖ´Â ±× º´¿øü¿¡ ´ëÇÑ Æ¯ÀÌ Ç×ü¸¦ »ý¼ºÇÏ°Ô µÇ´Âµ¥ ÀÌ Æ¯ÀÌÇס¦ |
|
ÀǾຸ°Ç  | 
4p age   | 
1,000 ¿ø
|
|
|
|
|
|
1.vocal fold anatomy and physiology: ±è¿µÈ£ 2.pathophysiology of vocal nodule and polyp: ±èÇüÅ 3.Evaluation of vocal nodule and polyp: È«±âȯ 4.Surgical management: ¼Õ¿µÀÍ 5.Voice therapy: ǥȿµ FileSize : 24K / 1.vocal fold anatomy and physiology: ±è¿µÈ£ 2.pathophysiology of vocal nodule and polyp: ±èÇüÅ 3.Evaluation of vocal nodule and po¡¦ |
|
ÀǾຸ°Ç  | 
6p age   | 
1,700 ¿ø
|
|
|
|
|
|
1.rationale of IV sadation 2.pharmacology 3.Åõ¿©¹æ¹ý 4.complications £¦ treatment 5.references FileSize : 38K / 1.rationale of IV sadation 2.pharmacology 3.Åõ¿©¹æ¹ý 4.complications £¦ treatment 5.references / ÃÖ±Ù conscious sedation¿¡ ´ëÇÑ °ü½ÉÀÌ ¼Ò¾ÆÄ¡°ú ¿µ¿ª »Ó ¾Æ´Ï¶ó ¼ºÀο¡ ÀÖ¾î¼, ´õ ³ª¾Æ°¡ Ä¡°úÀÌ¿ÜÀÇ ¿µ¿ª¿¡¼µµ ³ô¾ÆÁö°í ÀÖ´Ù. ÀÌ ±Û¿¡¼´Â propo¡¦ |
|
ÀǾຸ°Ç  | 
6p age   | 
1,100 ¿ø
|
|
|
|
|
|
ÇѹæÀ¸·Î Ä¡·á°¡ Àß µÇ´Â Áúȯ (ÇÑÀÇÇÐ ÇѾà ÇѾູ¿ë ) / ¸ñÂ÷ 1. Çѹæ°ú ¾çÀÇÇÐÀÇ Á¢±Ù¹æ¹ýÀÇ Â÷ÀÌ 2.ÇÑÀÇÇÐ Ä¡·á¹ýÀÇ Á¾·ù 1)¾à¹°(å·Úª)¿ä¹ý 2) ħ(öÝ) 3) ¶ä[±¸ : ϶] 4) ºÎÇ×(ݾùü) 5) ±â°ø(ѨÍí) 6) Ãß³ª(õÏÑÚ) 3. ÇѹæÀ¸·Î Ä¡·á°¡ Àß µÇ´Â Áúȯ 1) ¿øÀÎÀ» Àß ¾Ë ¼ö ¾ø´Â Áúȯ 2) ¸¸¼ºÁúȯ 3) ¿©¼º ƯÀ¯ÀÇ Áúȯ 4) ³ë³â±â¿¡ ¸¹ÀÌ ¹ß»ýÇÏ´Â Áúȯ 5) ¾î¸°ÀÌ Áúȯ 6) ¼¾çÀÇÇС¦ |
|
ÀǾຸ°Ç  | 
12p age   | 
1,200 ¿ø
|
|
|
|
|
|
1. À§ÀÇ ¼ÒÈÀÛ¿ë 2. Á¦»êÁ¦(antacids) FileSize : 135K / 1. À§ÀÇ ¼ÒÈÀÛ¿ë 2. Á¦»êÁ¦(antacids) / 1) À§¶õ À§´Â º¹° »óºÎ¿¡ À§Ä¡ÇÏ°í ÀÖ´Â Å« ÁÖ¸Ó´ÏÀ̸ç À§º®¾Ö´Â ¼ö¸¹Àº À§¼±ÀÌ ºÐÆ÷ÇÏ°í ÀÖ¾î ½Ä»ç ¶§¸¶´Ù ¾î¸¥À» ±âÁØÀ¸·Î ¾à 400~800mlÀÇ À§¾×(gastric juice)À» ºÐºñÇÑ´Ù. À§¼±¿¡´Â 3Á¾·ùÀÇ ¼¼Æ÷°¡ ¹ß°ßµÇ´Âµ¥, parietal cell(º®¼¼Æ÷), chief cell(ÁÖ¼¼Æ÷), ±×¸®°í mucus ¡¦ |
|
ÀǾຸ°Ç  | 
4p age   | 
1,100 ¿ø
|
|
|
|
|
|
±Þ¼º, ¸¸¼º Àü¿°º´ÀÇ °ü¸® (±Þ¼º ¸¸¼º Àü¿°º´ ±Þ¼ºÀü¿°º´ ¸¸¼ºÀü¿°º´) / ¸ñÂ÷ ¥° ¼Òȱâ°è ħÀÔ Àü¿°º´ 1) ÀåƼǪ½º (typhoid fever) 2) ÄÝ·¹¶ó (cholera) 3) ¼¼±Õ¼º ÀÌÁú (bacillary dysentery) 4)ÀåÃâÇ÷¼º ´ëÀå±Õ °¨¿°Áõ(´ëÀå±ÕO157) 5)Æú¸®¿À (±Þ¼ºÈ¸¹é¼ö¿°; poliomyelitis) 6)ÆĶóƼǪ½º (paratyphoid fever) ¥± È£Èí±â°è ħÀÔ Àü¿°º´ 1) µðÇÁÅ׸®¾Æ (diphtheria) 2) ¹éÀÏÇØ (wh¡¦ |
|
ÀǾຸ°Ç  | 
7p age   | 
1,500 ¿ø
|
|
|
|
|
|
1. Pediatric patientÀÇ characteristics 2. SedationÀÇ Á¾·ù 3. Routes Of Administraion For Conscious Sedation 4. Pharmacology of Drugs Used for Oral Sedation 5.Inhalation sedation: Nitrous Oxide and Oxygen 6.Postoperative Anesthetic periodÀÇ Management FileSize : 34K / 1. Pediatric patientÀÇ characteristics 2. SedationÀÇ Á¾·ù 3. Routes Of Administraio¡¦ |
|
ÀǾຸ°Ç  | 
5p age   | 
1,000 ¿ø
|
|
|
|
|
|
¡¥Reaction of pulp to bacteria 5.Polymicrobial infection 6.Microbial ecosystem in the root canal FileSize : 44K / 135.Polymicrobial infection 6.Microbial ecosystem in t |
|
ÀǾຸ°Ç  | 
6p age   | 
1,000 ¿ø
|
|
|
|
|
|
[°£È£] ÀÓ»ó°Ë»ç°á°úÀÇÀÇ / Ç׸ñ Á¤»ó¹üÁÖ °á°ú ÀÓ»óÀû ÀÇÀÇ Sodium 135-145 mEq/L °í ³ªÆ®·ýÇ÷Áõ : ¼öºÐ ¼·Ãë ºÎÁ· Àú ³ªÆ®·ýÇ÷Áõ : Å»¼ö, ÀüÇØÁú »ó½Ç Potassium 3.5-5mEq/L Áõ°¡: ¹è¼³Àå¾Ö(½ÅÁúȯ) °¨¼Ò: ¼öºÐ°úÀ×, À§Àå°ü ¼Õ½Ç chloride 103-111 mEq/L °í ¿°¼ÒÇ÷Áõ : ¼³»ç Àú ¿°¼ÒÇ÷Áõ : ±¸Åä, À§¾×»ó½Ç Albumin 3.1-5.2g/dL Àú¾ËºÎ¹Î Ç÷Áõ: ¸¸¼º°£Áúȯ, ´Ü¹éÁú¼·ÃëºÎÁ· Alkali¡¦ |
|
ÀǾຸ°Ç  | 
2p age   | 
1,000 ¿ø
|
|
|
|
|
|
Èæ»çº´Àº 1347³â¿¡¼ 1351³â »çÀÌ¿¡ °¡Àå ½É°¢Çß´ø À¯ÇິÀ¸·Î À¯·´ÀÇ Á¤Ä¡¡¤Á¾±³, »çȸ¡¤°æÁ¦, ¹®È¿¡ °Å¸ÇÏ¿´´Ù. ±× ÀÌÈÄ¿¡µµ 300¿© ³â µ¿¾È Èæ»çº´Àº ÁÖ±âÀûÀ¸·Î À¯·´À» °Å¸ÇÏ¿´´Ù. ÇÏÁö¸¸ 14¼¼±â À¯·´»çȸÀÇ À§±â¿¡ Èæ»çº´ÀÌ Á÷Á¢ÀûÀÎ ¿µÇâÀ» ÁÖ¾ú´ÂÁö, ¾Æ´Ï¸é ´Ù¸¥ ¿äÀεéÀÌ ÀÖ¾ú´ÂÁö¿¡ ´ëÇÑ ¿©·¯ °¡Áö ³í¶õÀÌ ÀÖ´Ù. 14¼¼±âÈæ»çº´°ú±×°ÍÀÌÀ¯·´»çȸ¿¡¹ÌÄ£¿µÇâ / ¥°. ½ÃÀÛÇÏ¸é¼ ¡¦ |
|
ÀǾຸ°Ç  | 
6p age   | 
1,300 ¿ø
|
|
|
|
|